ahlam1399
10-01-2016, 02:31 AM
Depomed wins Nucynta patent dispute; may spur sale talks
(Reuters) - A court ruled in Depomed Inc's favor in a patent dispute over its opioid drug, Nucynta, a decision that could help pave the way for the drug maker to explore a sale.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=E-O0fb868Is:_Kq7BrT_iVM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=E-O0fb868Is:_Kq7BrT_iVM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=E-O0fb868Is:_Kq7BrT_iVM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=E-O0fb868Is:_Kq7BrT_iVM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=E-O0fb868Is:_Kq7BrT_iVM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/E-O0fb868Is
(Reuters) - A court ruled in Depomed Inc's favor in a patent dispute over its opioid drug, Nucynta, a decision that could help pave the way for the drug maker to explore a sale.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=E-O0fb868Is:_Kq7BrT_iVM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=E-O0fb868Is:_Kq7BrT_iVM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=E-O0fb868Is:_Kq7BrT_iVM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=E-O0fb868Is:_Kq7BrT_iVM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=E-O0fb868Is:_Kq7BrT_iVM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/E-O0fb868Is